Showing results (11-20 of 112) with videos related to
Sort By:
Pageof 12
Journal of Cardiovascular Pharmacology|January 1, 1991
Effects of serotonin on platelets and blood vesselsF De ClerckAngiology|July 1, 1981
Protection by flunarizine against endothelial cell injury in vivoJ Hladovec, F De ClerckAgents and Actions|March 1, 1986
Effects of ketanserin, a selective 5-HT2 serotonergic antagonist, on the secondary recruitment of human platelets in vitroF De Clerck, B XhonneuxJournal of Cardiovascular Pharmacology|January 1, 1985
Continuous inhibition of platelet S2-serotonergic receptors during chronic administration of ketanserin in humansF De Clerck, B XhonneuxBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1990
5-Hydroxytryptamine and thromboxane A2 in ischaemic heart diseaseF De Clerck, P A JanssenJournal of Cardiovascular Pharmacology|July 1, 1993
R 56 865, a Na+/Ca(2+)-overload inhibitor, protects against aconitine-induced cardiac arrhythmias in vivoH R Lu, F De ClerckArchives Internationales De Pharmacodynamie Et De Therapie|August 1, 1975
Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. In vitro experimentsF De Clerck, J Vermylen, R RenemanThrombosis Research|September 15, 1982
Platelet-mediated vascular contractions: inhibition of the serotonergic component by ketanserinF De Clerck, J M Van NuetenCoronary Artery Disease|July 1, 1993
The protection by ischemic preconditioning against myocardial ischemia- and reperfusion-induced arrhythmias is not mediated by ATP-sensitive potassium channels in ratsH Lu, P Remeysen, F De ClerckArchives Internationales De Pharmacodynamie Et De Therapie|September 1, 1975
Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experimentsF De Clerck, J Vermylen, R RenemanPageof 12